360 related articles for article (PubMed ID: 27364640)
1. Final screening round of the NELSON lung cancer screening trial: the effect of a 2.5-year screening interval.
Yousaf-Khan U; van der Aalst C; de Jong PA; Heuvelmans M; Scholten E; Lammers JW; van Ooijen P; Nackaerts K; Weenink C; Groen H; Vliegenthart R; Ten Haaf K; Oudkerk M; de Koning H
Thorax; 2017 Jan; 72(1):48-56. PubMed ID: 27364640
[TBL] [Abstract][Full Text] [Related]
2. Occurrence and lung cancer probability of new solid nodules at incidence screening with low-dose CT: analysis of data from the randomised, controlled NELSON trial.
Walter JE; Heuvelmans MA; de Jong PA; Vliegenthart R; van Ooijen PMA; Peters RB; Ten Haaf K; Yousaf-Khan U; van der Aalst CM; de Bock GH; Mali W; Groen HJM; de Koning HJ; Oudkerk M
Lancet Oncol; 2016 Jul; 17(7):907-916. PubMed ID: 27283862
[TBL] [Abstract][Full Text] [Related]
3. Detection of lung cancer through low-dose CT screening (NELSON): a prespecified analysis of screening test performance and interval cancers.
Horeweg N; Scholten ET; de Jong PA; van der Aalst CM; Weenink C; Lammers JW; Nackaerts K; Vliegenthart R; ten Haaf K; Yousaf-Khan UA; Heuvelmans MA; Thunnissen E; Oudkerk M; Mali W; de Koning HJ
Lancet Oncol; 2014 Nov; 15(12):1342-50. PubMed ID: 25282284
[TBL] [Abstract][Full Text] [Related]
4. Characteristics of lung cancers detected by computer tomography screening in the randomized NELSON trial.
Horeweg N; van der Aalst CM; Thunnissen E; Nackaerts K; Weenink C; Groen HJ; Lammers JW; Aerts JG; Scholten ET; van Rosmalen J; Mali W; Oudkerk M; de Koning HJ
Am J Respir Crit Care Med; 2013 Apr; 187(8):848-54. PubMed ID: 23348977
[TBL] [Abstract][Full Text] [Related]
5. Risk stratification based on screening history: the NELSON lung cancer screening study.
Yousaf-Khan U; van der Aalst C; de Jong PA; Heuvelmans M; Scholten E; Walter J; Nackaerts K; Groen H; Vliegenthart R; Ten Haaf K; Oudkerk M; de Koning H
Thorax; 2017 Sep; 72(9):819-824. PubMed ID: 28360223
[TBL] [Abstract][Full Text] [Related]
6. Results of the Randomized Danish Lung Cancer Screening Trial with Focus on High-Risk Profiling.
Wille MM; Dirksen A; Ashraf H; Saghir Z; Bach KS; Brodersen J; Clementsen PF; Hansen H; Larsen KR; Mortensen J; Rasmussen JF; Seersholm N; Skov BG; Thomsen LH; Tønnesen P; Pedersen JH
Am J Respir Crit Care Med; 2016 Mar; 193(5):542-51. PubMed ID: 26485620
[TBL] [Abstract][Full Text] [Related]
7. Characteristics and Outcomes of Small Cell Lung Cancer Detected by CT Screening.
Thomas A; Pattanayak P; Szabo E; Pinsky P
Chest; 2018 Dec; 154(6):1284-1290. PubMed ID: 30080997
[TBL] [Abstract][Full Text] [Related]
8. Computed tomography screening for lung cancer: results of ten years of annual screening and validation of cosmos prediction model.
Veronesi G; Maisonneuve P; Rampinelli C; Bertolotti R; Petrella F; Spaggiari L; Bellomi M
Lung Cancer; 2013 Dec; 82(3):426-30. PubMed ID: 24099665
[TBL] [Abstract][Full Text] [Related]
9. Role of Low-Dose Computerized Tomography in Lung Cancer Screening among Never-Smokers.
Kang HR; Cho JY; Lee SH; Lee YJ; Park JS; Cho YJ; Yoon HI; Lee KW; Lee JH; Lee CT
J Thorac Oncol; 2019 Mar; 14(3):436-444. PubMed ID: 30445189
[TBL] [Abstract][Full Text] [Related]
10. Can CT Screening Give Rise to a Beneficial Stage Shift in Lung Cancer Patients? Systematic Review and Meta-Analysis.
Wang Z; Hu Y; Wang Y; Han W; Wang L; Xue F; Sui X; Song W; Shi R; Jiang J
PLoS One; 2016; 11(10):e0164416. PubMed ID: 27736916
[TBL] [Abstract][Full Text] [Related]
11. CT screening for lung cancer brings forward early disease. The randomised Danish Lung Cancer Screening Trial: status after five annual screening rounds with low-dose CT.
Saghir Z; Dirksen A; Ashraf H; Bach KS; Brodersen J; Clementsen PF; Døssing M; Hansen H; Kofoed KF; Larsen KR; Mortensen J; Rasmussen JF; Seersholm N; Skov BG; Thorsen H; Tønnesen P; Pedersen JH
Thorax; 2012 Apr; 67(4):296-301. PubMed ID: 22286927
[TBL] [Abstract][Full Text] [Related]
12. Different efficacy of CT screening for lung cancer according to histological type: analysis of Japanese-smoker cases detected using a low-dose CT screen.
Kondo R; Yoshida K; Kawakami S; Shiina T; Kurai M; Takasuna K; Yamamoto H; Koizumi T; Honda T; Kubo K
Lung Cancer; 2011 Dec; 74(3):433-40. PubMed ID: 21663995
[TBL] [Abstract][Full Text] [Related]
13. The Danish randomized lung cancer CT screening trial--overall design and results of the prevalence round.
Pedersen JH; Ashraf H; Dirksen A; Bach K; Hansen H; Toennesen P; Thorsen H; Brodersen J; Skov BG; Døssing M; Mortensen J; Richter K; Clementsen P; Seersholm N
J Thorac Oncol; 2009 May; 4(5):608-14. PubMed ID: 19357536
[TBL] [Abstract][Full Text] [Related]
14. Participant selection for lung cancer screening by risk modelling (the Pan-Canadian Early Detection of Lung Cancer [PanCan] study): a single-arm, prospective study.
Tammemagi MC; Schmidt H; Martel S; McWilliams A; Goffin JR; Johnston MR; Nicholas G; Tremblay A; Bhatia R; Liu G; Soghrati K; Yasufuku K; Hwang DM; Laberge F; Gingras M; Pasian S; Couture C; Mayo JR; Nasute Fauerbach PV; Atkar-Khattra S; Peacock SJ; Cressman S; Ionescu D; English JC; Finley RJ; Yee J; Puksa S; Stewart L; Tsai S; Haider E; Boylan C; Cutz JC; Manos D; Xu Z; Goss GD; Seely JM; Amjadi K; Sekhon HS; Burrowes P; MacEachern P; Urbanski S; Sin DD; Tan WC; Leighl NB; Shepherd FA; Evans WK; Tsao MS; Lam S;
Lancet Oncol; 2017 Nov; 18(11):1523-1531. PubMed ID: 29055736
[TBL] [Abstract][Full Text] [Related]
15. Smoking habits in the randomised Danish Lung Cancer Screening Trial with low-dose CT: final results after a 5-year screening programme.
Ashraf H; Saghir Z; Dirksen A; Pedersen JH; Thomsen LH; Døssing M; Tønnesen P
Thorax; 2014 Jun; 69(6):574-9. PubMed ID: 24443174
[TBL] [Abstract][Full Text] [Related]
16. Design, recruitment and baseline results of the ITALUNG trial for lung cancer screening with low-dose CT.
Lopes Pegna A; Picozzi G; Mascalchi M; Maria Carozzi F; Carrozzi L; Comin C; Spinelli C; Falaschi F; Grazzini M; Innocenti F; Ronchi C; Paci E;
Lung Cancer; 2009 Apr; 64(1):34-40. PubMed ID: 18723240
[TBL] [Abstract][Full Text] [Related]
17. Risk-based selection from the general population in a screening trial: selection criteria, recruitment and power for the Dutch-Belgian randomised lung cancer multi-slice CT screening trial (NELSON).
van Iersel CA; de Koning HJ; Draisma G; Mali WP; Scholten ET; Nackaerts K; Prokop M; Habbema JD; Oudkerk M; van Klaveren RJ
Int J Cancer; 2007 Feb; 120(4):868-74. PubMed ID: 17131307
[TBL] [Abstract][Full Text] [Related]
18. Characteristics of new solid nodules detected in incidence screening rounds of low-dose CT lung cancer screening: the NELSON study.
Walter JE; Heuvelmans MA; Bock GH; Yousaf-Khan U; Groen HJM; Aalst CMV; Nackaerts K; Ooijen PMAV; Koning HJ; Vliegenthart R; Oudkerk M
Thorax; 2018 Aug; 73(8):741-747. PubMed ID: 29661918
[TBL] [Abstract][Full Text] [Related]
19. Lung cancer probability in patients with CT-detected pulmonary nodules: a prespecified analysis of data from the NELSON trial of low-dose CT screening.
Horeweg N; van Rosmalen J; Heuvelmans MA; van der Aalst CM; Vliegenthart R; Scholten ET; ten Haaf K; Nackaerts K; Lammers JW; Weenink C; Groen HJ; van Ooijen P; de Jong PA; de Bock GH; Mali W; de Koning HJ; Oudkerk M
Lancet Oncol; 2014 Nov; 15(12):1332-41. PubMed ID: 25282285
[TBL] [Abstract][Full Text] [Related]
20. Sequential screening for lung cancer in a high-risk group: randomised controlled trial: LungSEARCH: a randomised controlled trial of Surveillance using sputum and imaging for the EARly detection of lung Cancer in a High-risk group.
Spiro SG; Shah PL; Rintoul RC; George J; Janes S; Callister M; Novelli M; Shaw P; Kocjan G; Griffiths C; Falzon M; Booton R; Magee N; Peake M; Dhillon P; Sridharan K; Nicholson AG; Padley S; Taylor MN; Ahmed A; Allen J; Ngai Y; Chinyanganya N; Ashford-Turner V; Lewis S; Oukrif D; Rabbitts P; Counsell N; Hackshaw A
Eur Respir J; 2019 Oct; 54(4):. PubMed ID: 31537697
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
